Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600 million round was led by Thrive Capital, with ...

The company, which is led and founded by Google DeepMind CEO Demis Hassabis, was built upon the foundation of DeepMind’s AlphaFold software, which uses machine learning to predict the structure ...

Mon, Mar 31, 2025, 11:43 AM2 min read Isomorphic Labs, Google’s artificial intelligence drug business, raised $600 million in its first external funding round, the company said on Monday.

Isomorphic Labs is led by AI pioneer Sir Demis Hassabis, and its founding was built on the Nobel-winning AI breakthrough, AlphaFold.

Demis Hassabis, the CEO of Google DeepMind, said humans are "infinitely adaptable."World Economic Forum/Gabriel Lado Google DeepMind CEO Demis Hassabis has said AI will create "very valuable jobs." If ...